Rtw Investments
Latest statistics and disclosures from Rtw Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RCKT, IMCR, AXSM, RARE, BRKR, and represent 27.62% of Rtw Investments's stock portfolio.
- Added to shares of these 10 stocks: SYK (+$115M), IMTX (+$90M), DYN (+$88M), MRUS (+$78M), Shockwave Med (+$73M), ALKS (+$58M), RDNT (+$51M), ACAD (+$48M), AKRO (+$47M), KYTX (+$46M).
- Started 16 new stock positions in RGNX, DNTH, DYN, KYTX, LENZ, NGNE, GKOS, XAIR, LRMR, SYK. CGON, JANX, ISRG, EXAS, SGMT, SABS.
- Reduced shares in these 10 stocks: Mirati Therapeutics (-$398M), , CLDX (-$137M), MDGL (-$112M), VCEL (-$84M), ARVN (-$38M), CRGX (-$32M), DHR (-$27M), SWTX (-$23M), TNGX (-$20M).
- Sold out of its positions in ALNY, APYX, CLDX, DHR, GH, Mirati Therapeutics, SAB Biotherapeutics, SIENQ, SGHT, SWTX. TNGX.
- Rtw Investments was a net seller of stock by $-97M.
- Rtw Investments has $6.8B in assets under management (AUM), dropping by 5.82%.
- Central Index Key (CIK): 0001493215
Tip: Access up to 7 years of quarterly data
Positions held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Rtw Investments
Rtw Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 7.0 | $477M | 18M | 26.94 |
|
|
| Immunocore Hldgs Ads (IMCR) | 5.8 | $391M | 6.0M | 65.00 |
|
|
| Axsome Therapeutics (AXSM) | 5.3 | $359M | 4.5M | 79.80 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 4.9 | $331M | +2% | 7.1M | 46.69 |
|
| Bruker Corporation (BRKR) | 4.6 | $314M | 3.3M | 93.94 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 3.9 | $263M | 667k | 393.72 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 3.8 | $256M | +22% | 14M | 18.49 |
|
| Natera (NTRA) | 3.5 | $237M | 2.6M | 91.46 |
|
|
| Ptc Therapeutics I (PTCT) | 3.2 | $216M | 7.4M | 29.09 |
|
|
| Masimo Corporation (MASI) | 3.2 | $215M | 1.5M | 146.85 |
|
|
| Avidity Biosciences Ord (RNA) | 3.0 | $203M | +19% | 8.0M | 25.52 |
|
| Merus N V (MRUS) | 2.7 | $185M | +73% | 4.1M | 45.03 |
|
| Cytokinetics Com New (CYTK) | 2.6 | $177M | 2.5M | 70.11 |
|
|
| Apogee Therapeutics (APGE) | 2.4 | $164M | +15% | 2.5M | 66.45 |
|
| Alkermes SHS (ALKS) | 2.4 | $164M | +55% | 6.1M | 27.07 |
|
| Protagonist Therapeutics (PTGX) | 2.3 | $154M | 5.3M | 28.93 |
|
|
| Penumbra (PEN) | 2.2 | $151M | 676k | 223.18 |
|
|
| Avadel Pharmaceuticals Sponsored Adr | 2.2 | $149M | +26% | 8.8M | 16.89 |
|
| Akero Therapeutics (AKRO) | 2.0 | $137M | +51% | 5.4M | 25.26 |
|
| Establishment Labs Holdings Ord (ESTA) | 2.0 | $136M | +7% | 2.7M | 50.90 |
|
| Arvinas Ord (ARVN) | 2.0 | $136M | -21% | 3.3M | 41.28 |
|
| Tarsus Pharmaceuticals (TARS) | 1.8 | $119M | +3% | 3.3M | 36.35 |
|
| Stryker Corporation (SYK) | 1.7 | $115M | NEW | 321k | 357.87 |
|
| Madrigal Pharmaceuticals (MDGL) | 1.6 | $106M | -51% | 397k | 267.04 |
|
| Immatics SHS (IMTX) | 1.6 | $105M | +573% | 10M | 10.51 |
|
| Sage Therapeutics (SAGE) | 1.5 | $103M | +5% | 5.5M | 18.74 |
|
| Shockwave Med | 1.4 | $94M | +343% | 289k | 325.63 |
|
| Dyne Therapeutics (DYN) | 1.3 | $88M | NEW | 3.1M | 28.39 |
|
| 89bio (ETNB) | 1.3 | $86M | +32% | 7.4M | 11.64 |
|
| Spyre Therapeutics Com New (SYRE) | 1.3 | $85M | 2.2M | 37.93 |
|
|
| Vericel (VCEL) | 1.2 | $84M | -50% | 1.6M | 52.02 |
|
| Cargo Therapeutics (CRGX) | 1.2 | $83M | -27% | 3.7M | 22.32 |
|
| RadNet (RDNT) | 1.2 | $83M | +156% | 1.7M | 48.66 |
|
| Thermo Fisher Scientific (TMO) | 0.9 | $64M | +121% | 111k | 581.21 |
|
| 10x Genomics Cl A Com (TXG) | 0.9 | $58M | 1.6M | 37.53 |
|
|
| Stoke Therapeutics (STOK) | 0.8 | $57M | +2% | 4.2M | 13.50 |
|
| Fulcrum Therapeutics (FULC) | 0.8 | $55M | +6% | 5.8M | 9.44 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $53M | +10% | 19M | 2.87 |
|
| Insmed Com Par $.01 (INSM) | 0.7 | $51M | 1.9M | 27.13 |
|
|
| Urogen Pharma (URGN) | 0.7 | $49M | +88% | 3.3M | 15.00 |
|
| Kyverna Therapeutics (KYTX) | 0.7 | $46M | NEW | 1.9M | 24.84 |
|
| Intuitive Surgical Com New (ISRG) | 0.6 | $40M | NEW | 99k | 399.09 |
|
| Neurogene (NGNE) | 0.6 | $39M | NEW | 769k | 50.90 |
|
| Janux Therapeutics (JANX) | 0.6 | $38M | NEW | 1.0M | 37.65 |
|
| Gh Research Ordinary Shares (GHRS) | 0.5 | $36M | 3.3M | 10.66 |
|
|
| Health Sciences Acq Corp 2 (OBIO) | 0.4 | $30M | 5.6M | 5.27 |
|
|
| Dianthus Therapeutics (DNTH) | 0.3 | $20M | NEW | 667k | 30.00 |
|
| Essa Pharma Com New (EPIX) | 0.3 | $20M | 2.3M | 8.49 |
|
|
| Lenz Therapeutics (LENZ) | 0.3 | $19M | NEW | 863k | 22.33 |
|
| Cg Oncology (CGON) | 0.3 | $18M | NEW | 414k | 43.90 |
|
| Tourmaline Bio (TRML) | 0.3 | $17M | +85% | 742k | 22.90 |
|
| Roivant Sciences SHS (ROIV) | 0.2 | $15M | 1.5M | 10.54 |
|
|
| Miragen Therapeutics (VRDN) | 0.2 | $11M | 606k | 17.51 |
|
|
| Adicet Bio (ACET) | 0.1 | $9.7M | 4.1M | 2.35 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $7.4M | NEW | 350k | 21.07 |
|
| Acelyrin (SLRN) | 0.1 | $6.6M | 978k | 6.75 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $6.6M | NEW | 95k | 69.06 |
|
| Allurion Technologies Com Shs (ALUR) | 0.1 | $6.1M | 3.5M | 1.75 |
|
|
| Immunic (IMUX) | 0.1 | $6.0M | +5% | 4.6M | 1.32 |
|
| Milestone Pharmaceuticals (MIST) | 0.1 | $5.8M | 3.3M | 1.79 |
|
|
| Glaukos (GKOS) | 0.1 | $5.5M | NEW | 59k | 94.29 |
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $5.4M | NEW | 999k | 5.42 |
|
| Larimar Therapeutics (LRMR) | 0.1 | $4.9M | NEW | 650k | 7.59 |
|
| Sab Biotherapeutics Com New (SABS) | 0.1 | $4.2M | NEW | 918k | 4.54 |
|
| Exagen (XGN) | 0.0 | $2.4M | 1.5M | 1.59 |
|
|
| Beyond Air (XAIR) | 0.0 | $2.1M | NEW | 1.2M | 1.74 |
|
| Cutera (CUTR) | 0.0 | $2.0M | -26% | 1.3M | 1.47 |
|
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.4M | 128k | 11.23 |
|
|
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $105k | 350k | 0.30 |
|
Past Filings by Rtw Investments
SEC 13F filings are viewable for Rtw Investments going back to 2014
- Rtw Investments 2024 Q1 filed May 15, 2024
- Rtw Investments 2023 Q4 filed Feb. 14, 2024
- Rtw Investments 2023 Q3 filed Nov. 14, 2023
- Rtw Investments 2023 Q2 filed Aug. 14, 2023
- Rtw Investments 2023 Q1 filed May 15, 2023
- Rtw Investments 2022 Q4 filed Feb. 14, 2023
- Rtw Investments 2022 Q3 filed Nov. 14, 2022
- Rtw Investments 2022 Q2 filed Aug. 15, 2022
- Rtw Investments 2022 Q1 filed May 16, 2022
- Rtw Investments 2021 Q4 filed Feb. 14, 2022
- Rtw Investments 2021 Q3 filed Nov. 15, 2021
- Rtw Investments 2021 Q2 filed Aug. 13, 2021
- Rtw Investments 2021 Q1 filed May 14, 2021
- Rtw Investments 2020 Q4 filed Feb. 16, 2021
- Rtw Investments 2020 Q3 filed Nov. 16, 2020
- Rtw Investments 2020 Q2 filed Aug. 14, 2020